Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis
R Boyd, N Ford, P Padgen… - The International Journal of …, 2017 - ingentaconnect.com
BACKGROUND: To reduce transmission and improve patient outcomes, rapid diagnosis
and treatment of rifampicin-resistant tuberculosis (RR-TB) is required. OBJECTIVE: To …
and treatment of rifampicin-resistant tuberculosis (RR-TB) is required. OBJECTIVE: To …
What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?
Background Drug-resistant tuberculosis (DR-TB) is undermining TB control in South Africa.
However, there are hardly any data about the cost of treating DR-TB in high burden settings …
However, there are hardly any data about the cost of treating DR-TB in high burden settings …
Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis
J Heyckendorf, ID Olaru, M Ruhwald… - American journal of …, 2014 - atsjournals.org
Tuberculosis (TB) differs from most other bacterial infectious diseases by a very long
duration of combination antibiotic therapy required to achieve relapse-free cure. Although …
duration of combination antibiotic therapy required to achieve relapse-free cure. Although …
A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB …
KH Chaiyachati, M Loveday, S Lorenz, N Lesh… - PloS one, 2013 - journals.plos.org
Introduction As the South African province of KwaZulu-Natal addresses a growing multidrug-
resistant tuberculosis (MDR-TB) epidemic by shifting care and treatment from trained …
resistant tuberculosis (MDR-TB) epidemic by shifting care and treatment from trained …
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis
Background: In settings with high tuberculosis (TB) prevalence, 15–30% of HIV-infected
individuals initiating antiretroviral therapy (ART) have undiagnosed TB. Such patients are …
individuals initiating antiretroviral therapy (ART) have undiagnosed TB. Such patients are …
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India
Background India carries one quarter of the global burden of multi-drug resistant TB (MDR-
TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of …
TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of …
Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis
ML Bastos, LB Cosme, G Fregona, TN do Prado… - BMC infectious …, 2017 - Springer
Background Multidrug-resistant tuberculosis (MDR-TB) is a threat for the global TB epidemic
control. Despite existing evidence that individualized treatment of MDR-TB is superior to …
control. Despite existing evidence that individualized treatment of MDR-TB is superior to …
A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?
A Berhan, Y Berhan, D Yizengaw - Ethiopian journal of health sciences, 2013 - ajol.info
Background: In Sub-Saharan Africa, the fight against tuberculosis (TB) has encountered a
great challenge because of the emergence of drug resistant TB strains and the high …
great challenge because of the emergence of drug resistant TB strains and the high …
Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa
SETTING: In KwaZulu-Natal, South Africa, a setting endemic for tuberculosis (TB) and the
human immunodeficiency virus (HIV), prolonged hospitalisation for the treatment of the …
human immunodeficiency virus (HIV), prolonged hospitalisation for the treatment of the …
Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia
A Shibabaw, B Gelaw, SH Wang, B Tessema - PloS one, 2018 - journals.plos.org
Background Sputum smear and culture conversions are an important indicator of treatment
efficacy and help to determine treatment duration in multidrug resistant tuberculosis (MDR …
efficacy and help to determine treatment duration in multidrug resistant tuberculosis (MDR …